Product News and Recalls

The most recent independent study was published today in the Canadian Medical Journal

The Canadian Medical Journal published an article today by Dr. Gronich from the Department of Community Medicine and Epidemiology, looking at approximately 330,000 women taking various birth control pills. Overall, they found that drospirenone, an ingredient in Yaz, Yasmin, Ocella, and Beyaz, had a 65% increased risk of causing blood clots when compared more established birth control pills, ...

December 8 Meeting Scheduled to Discuss 6 Studies Showing Increased Risk of Blood Clots

The FDA will hold hearings next month to consider the risks of blood clots associated with Yaz, Yasmin, Ocella, and Beyaz. Although approximately six studies now show an increased risk, the FDA has not yet determined whether to officially update the warnings on these pills. The agency is widely expected to make a decision at or shortly ...

Large study shows “significantly higher risk” compared with “low-estrogen” pills

The FDA announced today that it has published a large retrospective study showing that women on birth control pills that contain drospirenone, an ingredient in Yaz, Yasmin, Ocella, and Beyaz, are approximately 75% more likely to have a blood clot than women on safer, established birth control pills.

Combined with the Danish study announced in the New York Times this ...

Yet Another Study Shows Increased Risk of Blood Clots for Yaz, Yasmin,Ocella, and Beyaz

The New York Times announced today that “A new study of 1.3 million Danish women over nine years adds to the evidence that some newer birth-control pills, including the best-seller Yaz, have a higher risk of causing potentially dangerous blood clots.”  That makes approximately 5 studies in recent years suggesting a higher risk of blood clots ...